DE69729890D1 - Heilmittel/vorbeugemittel für erkrankungen der atemwege - Google Patents

Heilmittel/vorbeugemittel für erkrankungen der atemwege

Info

Publication number
DE69729890D1
DE69729890D1 DE69729890T DE69729890T DE69729890D1 DE 69729890 D1 DE69729890 D1 DE 69729890D1 DE 69729890 T DE69729890 T DE 69729890T DE 69729890 T DE69729890 T DE 69729890T DE 69729890 D1 DE69729890 D1 DE 69729890D1
Authority
DE
Germany
Prior art keywords
group
respiratory diseases
preventive
medicinal
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69729890T
Other languages
English (en)
Other versions
DE69729890T2 (de
Inventor
Takayuki Namiki
Masayuki Yuasa
Takako Takakuwa
Satoshi Ichinomiya
Masashi Tamai
Naoki Hiyama
Yukio Kawazu
Tomoaki Yahiro
Mayumi Sugio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pola Chemical Industries Inc
Original Assignee
Pola Chemical Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chemical Industries Inc filed Critical Pola Chemical Industries Inc
Publication of DE69729890D1 publication Critical patent/DE69729890D1/de
Application granted granted Critical
Publication of DE69729890T2 publication Critical patent/DE69729890T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69729890T 1997-02-14 1997-12-26 Heilmittel/vorbeugemittel für erkrankungen der atemwege Expired - Fee Related DE69729890T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP4719797 1997-02-14
JP4719797 1997-02-14
JP4721197 1997-02-14
JP4721197 1997-02-14
PCT/JP1997/004878 WO1998035968A1 (fr) 1997-02-14 1997-12-26 Produits therapeutiques/prophylactiques des maladies respiratoires

Publications (2)

Publication Number Publication Date
DE69729890D1 true DE69729890D1 (de) 2004-08-19
DE69729890T2 DE69729890T2 (de) 2005-07-14

Family

ID=26387351

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69729890T Expired - Fee Related DE69729890T2 (de) 1997-02-14 1997-12-26 Heilmittel/vorbeugemittel für erkrankungen der atemwege

Country Status (8)

Country Link
EP (1) EP0976754B1 (de)
JP (1) JP4192250B2 (de)
AT (1) ATE271051T1 (de)
AU (1) AU727572B2 (de)
CA (1) CA2279641A1 (de)
DE (1) DE69729890T2 (de)
NO (1) NO993911D0 (de)
WO (1) WO1998035968A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004075846A2 (en) 2003-02-25 2004-09-10 Bristol-Myers Squibb Company Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
WO2005087775A1 (ja) * 2004-03-15 2005-09-22 Ono Pharmaceutical Co., Ltd. 三環式複素環化合物およびその化合物を有効成分として含有する医薬組成物
WO2014139326A1 (en) * 2013-03-13 2014-09-18 Genentech, Inc. Pyrazolo compounds and uses thereof
CA2963051C (en) * 2014-12-08 2023-10-17 Janssen Sciences Ireland Uc Piperidine substituted pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (rsv)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0688999B2 (ja) * 1988-10-13 1994-11-09 ポーラ化成工業株式会社 ピロロ〔３，２―ｅ〕ピラゾロ〔１，５―ａ〕ピリミジン誘導体およびこれを含有する医薬
JPH07242670A (ja) * 1994-03-08 1995-09-19 Pola Chem Ind Inc ピロロ［３，２−ｅ］ピラゾロ［１，５−ａ］ピリミジン誘導体及びこれを含有する循環器系疾患治療剤
JPH07267960A (ja) * 1994-03-28 1995-10-17 Lederle Japan Ltd ピロロ［３，２−ｅピラゾロ［１，５−ａピリミジン誘導体及びこれを含有する循環器系疾患治療剤
JPH10218881A (ja) * 1997-02-03 1998-08-18 Pola Chem Ind Inc 新規なピロロピラゾロピリミジン誘導体

Also Published As

Publication number Publication date
NO993911L (no) 1999-08-13
AU727572B2 (en) 2000-12-14
ATE271051T1 (de) 2004-07-15
WO1998035968A1 (fr) 1998-08-20
EP0976754A4 (de) 2001-01-10
JP4192250B2 (ja) 2008-12-10
NO993911D0 (no) 1999-08-13
EP0976754A1 (de) 2000-02-02
AU8705198A (en) 1998-09-08
DE69729890T2 (de) 2005-07-14
EP0976754B1 (de) 2004-07-14
CA2279641A1 (en) 1998-08-20

Similar Documents

Publication Publication Date Title
NO20020968D0 (no) Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav
CY1111951T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
FI950309A0 (fi) Proliiniamidijohdannaisia
DK0976748T3 (da) Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet
DE69935718D1 (de) Antidiabetische medikamente
IL169184A0 (en) Aromatic compounds as anti-inflammatory, immunomdulatory and anti-proliferatory agents
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
ATE239741T1 (de) Derivate der phosphonsäure zur inhibierung von carboxypeptidase b
DE69931378D1 (de) Chinazolin derivate und therapeutische verwendungen davon
DE69729890D1 (de) Heilmittel/vorbeugemittel für erkrankungen der atemwege
DE69812028D1 (de) Creatine Derivate für Asthma
DE60238847D1 (de) Pyrimidinderivate enthaltendes medikament

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee